Diabetes Mellitus and Prostate Cancer Risk in Asian Countries: a Meta-analysis

  • Long, Xiang-Ju (Department of Nephrology, the First Affiliated Hospital of Tianjin Medical University) ;
  • Lin, Shan (Department of Nephrology, the First Affiliated Hospital of Tianjin Medical University) ;
  • Sun, Ya-Nan (School of Basic Medical Sciences, Tianjin Medical University) ;
  • Zheng, Zhen-Feng (Department of Nephrology, the First Affiliated Hospital of Tianjin Medical University)
  • Published : 2012.08.31


Background/Aims: Diabetes mellitus (DM) is widely considered to be associated with risk of cancer, but studies investigating the association between DM and prostate cancer in Asian countries have reported inconsistent findings. We examined this association by conducting a detailed meta-analysis of studies published on the subject. Methods: Cohort or case-control studies were identified by searching Pubmed, Embase and Wanfang databases through May 30, 2012. Pooled relative risk (RR) with its corresponding 95% confidence interval (95% CI) were calculated using the random-effects model. Subgroup analyses were performed by the study type. Results: Finally, we identified 7 studies (four cohort studies and three case-control studies) with a total of 1,751,274 subjects from Asians. DM was associated with an increased risk of prostate cancer in Asians (unadjusted RR= 2.82, 95% CI, P < 0.001; adjusted RR= 1.31, 95% CI, P = 0.001). Subgroup analyses by study design further confirmed an obvious association. Conclusion: Findings from this meta-analysis strongly support that diabetes is associated with an increased risk of prostate cancer in Asians.


  1. Barone BB, Yeh HC, Snyder CF, et al (2008). Long-term allcause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA, 300, 2754-64.
  2. Bonovas S, Filioussi K ,Tsantes A (2004). Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia, 47, 1071-8.
  3. Chan JC, Malik V, Jia W, et al (2009). Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA, 301, 2129-40.
  4. Chen CQ, Fang LK, Cai SR, et al (2010). Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients. Chin Med J (Engl), 123, 3084-8.
  5. Chiou WK, Hwang JS, Hsu KH, et al (2012). Diabetes mellitus increased mortality rates more in gender-specific than in nongender-specific cancer patients: a retrospective study of 149,491 patients. Exp Diabetes Res, 2012, 701643.
  6. Damber JE, Aus G (2008). Prostate cancer. Lancet, 371, 1710-21.
  7. DerSimonian R ,Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
  8. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
  9. Foulkes WD (2008). Inherited susceptibility to common cancers. N Engl J Med, 359, 2143-53.
  10. Fukushima H, Masuda H, Kawakami S, et al (2012). Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL. Urology, 79, 1329-34.
  11. Ganesh B, Saoba SL, Sarade MN, et al (2011). Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India. Indian J Urol, 27, 345-50.
  12. Gann PH, Hennekens CH, Ma J, et al (1996). Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst, 88, 1118-26.
  13. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
  14. Hoffman RM (2011). Clinical practice. Screening for prostate cancer. N Engl J Med, 365, 2013-9.
  15. Hong SK, Oh JJ, Byun SS, et al (2012). Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (>/= 12)-core prostate biopsy. Prostate, 72, 51-7.
  16. Hsieh MC, Lee TC, Cheng SM, et al (2012). The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the taiwanese. Exp Diabetes Res, 2012, 413782.
  17. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
  18. Kasper JS ,Giovannucci E (2006). A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 15, 2056-62.
  19. Lee MY, Lin KD, Hsiao PJ, et al (2012). The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism, 61, 242-9.
  20. Li Q, Kuriyama S, Kakizaki M, et al (2010). History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study. Cancer Causes Control, 21, 1025-32.
  21. McGrowder DA, Jackson LA ,Crawford TV (2012). Prostate cancer and metabolic syndrome: is there a link? Asian Pac J Cancer Prev, 13, 1-13.
  22. Mori M, Masumori N, Fukuta F, et al (2011). Weight gain and family history of prostate or breast cancers as risk factors for prostate cancer: results of a case-control study in Japan. Asian Pac J Cancer Prev, 12, 743-7.
  23. Nolan CJ, Damm P, Prentki M (2011). Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet, 378, 169-81.
  24. Onitilo AA, Engel JM, Glurich I, et al (2012). Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control, 23, 967-81.
  25. Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, et al (2000). Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control, 11, 707-11.
  26. Snyder CF, Stein KB, Barone BB, et al (2010). Does pre-existing diabetes affect prostate cancer prognosis? A systematic review. Prostate Cancer Prostatic Dis, 13, 58-64.
  27. Tseng CH (2011). Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care, 34, 616-21.
  28. Tsugane S, Inoue M (2010). Insulin resistance and cancer: epidemiological evidence. Cancer Sci, 101, 1073-9.

Cited by

  1. Diabetes mellitus and risk of cancer in Takayama: A population-based prospective cohort study in Japan vol.104, pp.10, 2013,
  2. Association between metabolic syndrome, diabetes mellitus and prostate cancer risk pp.1476-5608, 2013,
  3. Association Between Gestational Diabetes Mellitus and Subsequent Risk of Cancer: a Systematic Review of Epidemiological Studies vol.15, pp.10, 2014,
  4. Difference in the Incidences of the Most Prevalent Urologic Cancers from 2003 to 2009 in Iran vol.15, pp.3, 2014,
  5. Association Analysis of Single Nucleotide Polymorphisms in miR-146a and miR-196a2 on the Prevalence of Cancer in Elderly Japanese: A Case-Control Study vol.15, pp.5, 2014,
  6. Diabetes Mellitus and HbA1c Levels Associated with High Grade Prostate Cancer vol.15, pp.6, 2014,
  7. The Metabolic Syndrome is Associated with More Aggressive Prostate Cancer vol.15, pp.9, 2014,
  8. Evaluation of Environmental Risk Factors for Prostate Cancer in a Population of Iranian Patients vol.15, pp.24, 2015,
  9. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium vol.60, pp.6, 2017,
  10. Impact of metformin on serum prostate-specific antigen levels vol.96, pp.51, 2017,
  11. Retrospective database analysis of cancer risk in patients with type 2 diabetes mellitus in China vol.34, pp.6, 2018,
  12. Epidemiology of prostate cancer in Asian countries vol.25, pp.6, 2018,
  13. Prospective study of cancer in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry pp.2190-1686, 2019,